CROI 2024 Program Guide

Oral Abstract Sessions

Trends in HIV and HCV Prevention Efforts and Incidence Among People Who Inject Drugs in Baltimore Eshan U. Patel , Becky Genberg, Bryan Lau, Jacqueline E Rudolph, Jacquie Astemborski, Rachel E Gicquelais, Danielle German, David D Celentano, David Vlahov, Steffanie Strathdee, Greg Kirk, David Thomas, Shruti H Mehta Preclinical Pharmacokinetic Assessment of a Hepatitis C Virus Long-Acting Injectable Formulation Usman Arshad , Henry Pertinez, Joanne Sharp, Joanne Herriott, Edyta Kijak, Eduardo Gallardo-Toledo, Andrew B Dwyer, Catherine Unsworth, Alison C Savage, James J Hobson, Lee Tatham, David Thomas, Paul Curley, Steve Rannard, Andrew Owen Intrahepatic HDV Activity Is Fueled by Integrated HBV DNA Derived HBs Independently From cccDNA Size Stefano D’Anna , Lorenzo Piermatteo, Elisabetta Teti, Andrea Di Lorenzo, Giuseppina Brancaccio, Umberto Cillo, Alessandro Vitale, Leonardo Baiocchi, Antonella Olivero, Giovanni Battista Gaeta, L Sarmati, Mario Rizzetto, Gian Paolo Caviglia, Valentina Svicher, Romina Salpini A 4-Month Regimen of Quabodepistat, Delamanid, and Bedaquiline for Pulmonary TB: Interim Results Rodney Dawson, Andreas H Diacon, Simbarashe Takuva , Yongge Liu, Bo Zheng, Vatsala Karwe, Tomohiro Sasaki, Jeffrey Hafkin Provisional Results From a 3-Month Clofazimine/Rifapentine Containing Regimen for Drug-Sensitive TB John Metcalfe , Isabelle Weir, Kimberly K Scarsi, Samuel Pierre, Austin Van Grack, Cecilia Kanyama, Maxwell Yohane, Wadzanai Samaneka, Neetal Nevrekar, Jorge Leon-Cruz, Alberto Mendoza-Ticona, Melanie Goth, Richard E Chaisson, for the ACTG A5362 CLO-FAST Study Team

160 11:00 AM

161 11:08 AM

162 11:16 AM NIS

163 11:24 AM LB

164 11:32 AM LB

Questions and Answers (Part 2)

Tuesday

Oral Abstract Session-09 | Leaning Into the Success of Biomedical HIV Prevention 10:00 AM - 12:00 PM • Mile High Ballroom 4

Moderators Nomathemba Chandiwana , University of the Witwatersrand, Johannesburg, South Africa Meredith Clement , Louisiana State University, New Orleans, LA, USA

Introductions (Part 1)

165 10:05 AM

Association of State-Level PrEP Coverage and State-Level HIV Diagnoses, US, 2012-2021 Patrick S. Sullivan , Stephanie Dubose, Kamaria Brisco, Gordon Le, Marta Juhasz HIV Incidence in Users of HIV Preexposure Prophylaxis in Australia: A Whole-of-Population Analysis Nicholas A. Medland , Hamish McManus, Benjamin Bavinton, Michael Traeger, Doug Fraser, Andrew Grulich, Mark Stoove, Skye McGregor, Jonathan King, Dash Heath-Paynter, Rebecca Guy

166 10:13 AM

CROI 2024 44

New Investigator Scholarship

LB

NIS

Late-Breaking